In order to strengthen Alligator’s research and development programs, the company collaborates with leading experts in clinical development of novel immunotherapy drugs. Alligator currently works with the following scientific advisors:
Professor Mario Sznol
Dr. Mario Sznol is a Professor of Medicine (Medical Oncology) at Yale School of medicine, New Haven, CT. Dr. Sznol is an expert in cancer immunotherapy and has an international reputation in cancer drug development and treatment of patients with melanoma and renal cell carcinoma.
Professor Jeffrey Weber
Professor Jeffrey Weber, Perlmutter Cancer Center at Langone Medical Center, New York, , USA, is an expert in clinical immuno-oncology. Professor Weber has led several clinical studies of e.g. CTLA-4 and PD-1 blocking antibodies and is one of the pioneers in management of autoimmune adverse events induced by immunotherapies.
Professor Ignacio Melero
Professor Ignacio Melero, University of Navarra, Spain is an expert in immunotherapy for cancer. Professor Melero´s research focuses on translational studies of e.g. the TNF receptor superfamily and clinical development of immunotherapeutic drugs.
Associate Professor Gregory Beatty
Dr Gregory Beatty (MD, PhD) is an Associate Professor at University of Pennsylvania Perelman School of Medicine, USA. Dr. Beatty’s clinical expertise is in early clinical trials for the treatment of gastrointestinal malignancies including pancreas, esophageal and colon carcinomas and he has led the first clinical study of CD40 immunotherapy for pancreatic cancer.
Associate Professor Michael Curran
Dr. Michael Curran, Associate Professor at the Department of Immunology, MD Anderson Cancer Center, Houston, Texas, US, is an expert in immuno-oncology. Research in the Curran Laboratory focuses on discovering mechanisms by which immune-resistant cancers evade the host T cell response and resist checkpoint antibody therapy.